-
Mashup Score: 1
Rachel Giles (chair of IKCC) describes her data from patients on these topics in RCC
Source: Spotify for PodcastersCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 2Diet Soda, Cancer, and the WHO by Docs Who Lift - 10 month(s) ago
Drs. Karl and Spencer chat with Dr. Andrea Love, a cancer immunologist, about the recent headlines about the WHO listing aspartame as a possible carcinogen.
Source: Spotify for PodcastersCategories: Cardiologists, Latest HeadlinesTweet-
We chatted with @dr_andrealove about the recent WHO and aspartame possible carcinogen listing on the docs who lift podcast https://t.co/0ETHSrc73V @DrKarlNadolsky Written while drinking a Fresca
-
-
Mashup Score: 10Episode 252: Talazoparib and its FDA approval in CRPC by The Uromigos - 10 month(s) ago
Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs
Source: Spotify for PodcastersCategories: Latest Headlines, Oncologists2Tweet-
RT @brian_rini: Great podcast on TALAPRO-2 and PARP inhibitors in prostate cancer with @neerajaiims https://t.co/XQ9Gdb6xU4
-
-
Mashup Score: 4
In this latest episode of ASTCT Talks, the June President’s Message, we are joined by Dr. Miguel Perales, President of ASTCT and Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College. This episode features a personal story of a patient with aggressive lymphoma who initially had doubts about the…
Source: Spotify for PodcastersCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
ICYMI: ASTCT President @DrMiguelPerales last President’s Message took the form of an ASTCT Talks podcast episode! Listen to his discussion about the primary barriers to access in the field and the initiatives undertaken by ASTCT to address these obstacles: https://t.co/JYMUryU37E https://t.co/j9yuPY3Zjv
-
-
Mashup Score: 4Episode 252: Talazoparib and its FDA approval in CRPC by The Uromigos - 10 month(s) ago
Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs
Source: Spotify for PodcastersCategories: Latest Headlines, Oncologists1Tweet-
RT @brian_rini: Great podcast on TALAPRO-2 and PARP inhibitors in prostate cancer with @neerajaiims https://t.co/XQ9Gdb6xU4
-
-
Mashup Score: 0Episode 252: Talazoparib and its FDA approval in CRPC by The Uromigos - 10 month(s) ago
Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and BRCA1/2 occurs
Source: Spotify for PodcastersCategories: Latest Headlines, Partners & KOLsTweet-
Great podcast on TALAPRO-2 and PARP inhibitors in prostate cancer with @neerajaiims https://t.co/XQ9Gdb6xU4
-
-
Mashup Score: 30Nina Teicholz How to Beat the Powerful Big Fat Health Lies Making Us Sick PART 1 by Family Health Lab - 10 month(s) ago
Nina Teicholz on How to Beat the Powerful Big Fat Health Lies Making Us Sick PART 1 Join Claire McDonnell Liu with Nina Teicholz, author of The Big Fat Surprise 00:55 How Nina started her day in New York 02:19 Childhood obesity, issues with the data, and 03:30 Nina highlights the lack of reporting on obesity, until recent pharmaceutical drugs such as Ozempic injections 05:00 What is causing our…
Source: Spotify for PodcastersCategories: Healthcare Professionals, Latest HeadlinesTweet-
So delighted to talk to my friend @familyhealthlab about our health crisis and its cause: our food system is broken, corporate capture, and misguided advice on how to get healthy. https://t.co/GryB7wwrX0 https://t.co/34aWOiuksb
-
-
Mashup Score: 9
Drs. Karl and Spencer chat with Dr. Pearl all about internalized bias and her recent study on it Click here to read the study
Source: Spotify for PodcastersCategories: Cardiologists, Latest HeadlinesTweet-
My brother @DrKarlNadolsky and I chatted with Dr. Rebecca Pearl all about internalized bias in obesity and what to do about it. A very good listen! https://t.co/11SqK9XmpO
-
-
Mashup Score: 0Episode 249: Bob Motzer discusses IPI/Nivo vs VEGF/PD1 by The Uromigos - 10 month(s) ago
After the discussion with Mike Atkins, Bob Motzer gives his perspective of the 1st line renal cancer situation .
Source: Spotify for PodcastersCategories: Latest Headlines, Partners & KOLsTweet-
Part 2 of the treatment of renal cancer with @motzermd, addressing the issues in 1st line renal cancer raised by Mike Akins #ASCO23 . https://t.co/ORDD3hzJ1L https://t.co/FJTq2mYwk0
-
-
Mashup Score: 12A chat with Dr. Salas-Whalen by Docs Who Lift - 11 month(s) ago
Drs. Karl and Spencer chat with Dr. Salas-Whalen, an endocrinologist, about getting the appropriate clinician to prescribe you GLP-1 medicines.
Source: Spotify for PodcastersCategories: Cardiologists, Latest HeadlinesTweet-
Is your doctor qualified to prescribe GLP-1s? Docs Who Lift chat with Dr. Salas-Whalen of New York Endocrinology about why it’s important to get a good doctor when using these meds. @DrKarlNadolsky https://t.co/5QEua4trSJ
-
Check out our latest podcast on RCC patient advocacy with Rachel Giles of IKCC! https://t.co/kPxURQ8zFk